{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:22:01Z","timestamp":1787062921044,"version":"build-2736575974"},"reference-count":24,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0230678","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T13:35:47Z","timestamp":1584711347000},"page":"e0230678","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-8133","authenticated-orcid":true,"given":"Mitsuru","family":"Arima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohta","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Nakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Ohga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koh-Hei","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"pone.0230678.ref001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/pr.2013.205","article-title":"Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010","volume":"74","author":"H Blencowe","year":"2013","journal-title":"Pediatr Res"},{"key":"pone.0230678.ref002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"American Academy of Pediatrics Section on Ophthalmology","year":"2013","journal-title":"Pediatrics"},{"key":"pone.0230678.ref003","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.ophtha.2016.03.026","article-title":"Changes in course of retinopathy of prematurity from 1986 to 2013: Comparison of three studies in the United States","volume":"123","author":"GE Quinn","year":"2016","journal-title":"Ophthalmology"},{"key":"pone.0230678.ref004","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2015.10244","article-title":"Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993\u20132012","volume":"314","author":"BJ Stoll","year":"2015","journal-title":"JAMA"},{"key":"pone.0230678.ref005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09286586.2018.1562082","article-title":"Change in the incidence and severity of retinopathy of prematurity (ROP) in a neonatal intensive care unit in northern India after 20 years: Comparison of two similar prospective cohort studies","volume":"26","author":"D Dhingra","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"key":"pone.0230678.ref006","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 Retinopathy of Prematurity","volume":"124","author":"DK VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"key":"pone.0230678.ref007","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"key":"pone.0230678.ref008","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"BEAT-ROP Cooperative Group","year":"2011","journal-title":"N Engl J Med"},{"key":"pone.0230678.ref009","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","article-title":"Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: A 5-year retrospective analysis","volume":"122","author":"CK Hwang","year":"2015","journal-title":"Ophthalmology"},{"key":"pone.0230678.ref010","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2014.05.015","article-title":"Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of Prematurity","volume":"121","author":"D Lepore","year":"2014","journal-title":"Ophthalmology"},{"key":"pone.0230678.ref011","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"J Morin","year":"2016","journal-title":"Pediatrics"},{"key":"pone.0230678.ref012","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"pone.0230678.ref013","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment For Retinopathy Of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"pone.0230678.ref014","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1440-1819.2009.01931.x","article-title":"Utility of the Kyoto Scale of Psychological development in cognitive assessment of children with pervasive developmental disorders","volume":"63","author":"T Koyama","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"pone.0230678.ref015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1589\/jpts.30.1019","article-title":"Relationship between the use of lower extremity orthoses and the developmental quotient of the Kyoto Scale of Psychological Development in children with Down syndrome","volume":"30","author":"Y Kanai","year":"2018","journal-title":"J Phys Ther Sci"},{"key":"pone.0230678.ref016","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.braindev.2015.11.001","article-title":"Comparison of the Kyoto Scale of Psychological Development 2001 with the parent-rated Kinder Infant Development Scale (KIDS)","volume":"38","author":"S Aoki","year":"2016","journal-title":"Brain Dev"},{"key":"pone.0230678.ref017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2011.07.005","article-title":"Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity","volume":"153","author":"T Sato","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"pone.0230678.ref018","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","article-title":"Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity","volume":"37","author":"WC Wu","year":"2017","journal-title":"Retina"},{"key":"pone.0230678.ref019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4161\/org.6.2.11687","article-title":"VEGF in the nervous system","volume":"6","author":"JM Rosenstein","year":"2010","journal-title":"Organogenesis"},{"key":"pone.0230678.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a006551","article-title":"Molecular parallels between neural and vascular development","volume":"3","author":"A Eichmann","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"pone.0230678.ref021","doi-asserted-by":"crossref","first-page":"e0148019","DOI":"10.1371\/journal.pone.0148019","article-title":"Neurodevelopmental outcomes in infants with retinopathy of prematurity and bevacizumab treatment","volume":"11","author":"R Lien","year":"2016","journal-title":"PLoS One"},{"key":"pone.0230678.ref022","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3928\/23258160-20190605-01","article-title":"Neurodevelopmental outcomes comparing bevacizumab to laser for type 1 ROP","volume":"50","author":"SH Rodriguez","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"pone.0230678.ref023","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1001\/jamapediatrics.2015.2175","article-title":"Prognostic factors for poor cognitive development in children born very preterm or with very low birth weight","volume":"169","author":"L Linsell","year":"2015","journal-title":"JAMA Pediatr"},{"key":"pone.0230678.ref024","first-page":"1","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"6736","author":"A Stahl","year":"2019","journal-title":"Lancet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T13:35:55Z","timestamp":1584711355000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0230678"}},"subtitle":[],"editor":[{"given":"Demetrios G.","family":"Vavvas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0230678","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}